Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | The unmet needs of glioblastoma

Maximilian Mair • 12 Sep 2022
ESMO 2022
Brain Tumor Glioblastoma

Maximilian Mair, MD, Medical University of Vienna, Vienna, Austria, discusses the key unmet needs of glioblastoma. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Maximilian Mair

2:23
Highlights in glioblastoma at ESMO 2022
Maximilian Mair • 12 Sep 2022
1:37
Radiomics-based prediction of lymphocyte infiltration in IDH-wildtype glioblastoma
Maximilian Mair • 12 Sep 2022
0:38
The use of radiomics to identify predictive biomarkers of immuntherapy in glioblastoma
Maximilian Mair • 12 Sep 2022

Related Videos

2:19
Clinical advances in brain cancer: AZD1390 and CAR-T cells in glioma
Patrick Wen • 12 Apr 2024
1:07
Genomic predictors of adverse events in glioblastoma
Patrick Wen • 12 Apr 2024
2:48
Clinical advances in the management of gliomas
Patrick Wen • 12 Apr 2024
0:54
Identifying molecular biomarkers for treatment response to bortezomib in glioblastoma
Martha Chekenya • 7 Apr 2024
The content of VJOncology is intended for healthcare professionals